Secondary analysis of a combined harm‐reduction treatment and extended‐release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth

Ejemplares similares

• Comparative effectiveness of extended‐release naltrexone versus buprenorphine‐naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population‐based observational data
  por: Sara Lodi, et al.
  Publicado: (2025)
• Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double‐blind, placebo‐controlled trial
  por: Henri‐Jean Aubin, et al.
  Publicado: (2024)
• Player tracking in itself may not be enough for efficient reduction of gambling harm, but combined with a personal gambling license could provide new possibilities to tracking gambling‐related harm
  por: Janne Nikkinen
  Publicado: (2024)
• Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019–21
  por: Erin Takemoto, et al.
  Publicado: (2024)
• Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA
  por: Caitlin M. Turner, et al.
  Publicado: (2025)